“I love my partner. I just never think about sex anymore.”
Low desire can disappear long before affection does.
Desire starts in the brain.
Prescription PT-141 Nasal Spray · 5 mg/mL
When desire goes quiet
You still love them. You just stopped wanting sex.
PT-141 acts in the brain on desire and arousal, the part before touch.
“Once things start, I enjoy it. Getting there feels impossible.”
PT-141 acts on brain signaling involved in desire and arousal—the part before touch.
“I want desire—not just lubrication.”
Blood flow handles the physical response. PT-141 targets the desire that comes first.
The nasal presentation
A refrigerated 5 mL bottle with metered nasal-spray delivery.
Your prescription label will list the strength, directions, storage, beyond-use date, and dispensing pharmacy.
Start online visit →What the pivotal trials measured
1,267Premenopausal women randomized across two phase 3 trials.
For 24 weeks, the RECONNECT studies compared 1.75 mg subcutaneous bremelanotide with placebo. They measured change in desire and distress related to low desire.
Read the phase 3 publication ↗On demand. On your terms.
Desire on demand. No needles. No pressure.
Use it on demand in seconds. The prescription label will pair the 5 mg/mL concentration with the pump’s metered output, sprays per dose, timing, and maximum frequency.
Bremelanotide injection safety
Not for uncontrolled high blood pressure or cardiovascular disease.
The FDA-approved injection is contraindicated in uncontrolled hypertension or known cardiovascular disease. Its label also addresses temporary blood-pressure increases, heart-rate reduction, nausea, focal hyperpigmentation, pregnancy, delayed gastric emptying, and oral naltrexone.
Read the FDA prescribing information ↗Another needle-free format
PT-141 troche is available too.
See troche details →Available now
Ready to see whether PT-141 fits?
Complete a private online visit for clinician review.